ALTB-268 – Patient Worthy

https://pixabay.com/en/anatomical-anatomy-body-gut-health-2261006/

Positive Topline Data Available on ALTB-268 for Ulcerative Colitis

Post author:Jessica Lynn
Post published:August 8, 2023
Post category:ulcerative Colitis

In a Phase 1 clinical study, researchers wanted to understand whether ALTB-268, developed by clinical-stage biotechnology company AltruBio Inc., could be effective in treating ulcerative colitis. The study first…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More